Pharmaceutical Industry Reports

Reports > Pharmaceutical > Selected Report

Global PDE Inhibitors Market Report for Period 2017 till 2023

Single User: $0
Multiple User: $0
Enterprise User: $0


Report Summary:

In this report, the global PDE Inhibitors market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (), revenue (Million USD), market share and growth rate of PDE Inhibitors for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global PDE Inhibitors market competition by top manufacturers/players, with PDE Inhibitors sales volume, Price (), revenue (Million USD) and market share for each manufacturer/player; the top players including
Hanmi Science Holding
Boehringer Ingelheim
Takeda Pharmaceuticals
Pfizer
Omeros
Anacor Pharmaceuticals
Otsuka
Chiesi Farmaceutici
Verona Pharma
NuSirt Biopharma
On the basis of product, this report displays the sales volume (), revenue (Million USD), product price (), market share and growth rate of each type, primarily split into
PDE5
PDE4
Viagra
Cialis
Levitra
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of PDE Inhibitors for each application, including
GENITOURINARY
CARDIOVASCULAR DISEASES
NEUROLOGICAL DISEASES
DERMATOLOGICAL DISORDERS
RESPIRATORY DISEASES
OTHER INDICATIONS

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents / Index:

Table of Contents

Global PDE Inhibitors Sales Market Report 2017
1 PDE Inhibitors Market Overview
1.1 Product Overview and Scope of PDE Inhibitors
1.2 Classification of PDE Inhibitors by Product Category
1.2.1 Global PDE Inhibitors Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global PDE Inhibitors Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 PDE5
1.2.4 PDE4
1.2.5 Viagra
1.2.6 Cialis
1.2.7 Levitra
1.2.8 Others
1.3 Global PDE Inhibitors Market by Application/End Users
1.3.1 Global PDE Inhibitors Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 GENITOURINARY
1.3.3 CARDIOVASCULAR DISEASES
1.3.4 NEUROLOGICAL DISEASES
1.3.5 DERMATOLOGICAL DISORDERS
1.3.6 RESPIRATORY DISEASES
1.3.7 OTHER INDICATIONS
1.4 Global PDE Inhibitors Market by Region
1.4.1 Global PDE Inhibitors Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States PDE Inhibitors Status and Prospect (2012-2022)
1.4.3 China PDE Inhibitors Status and Prospect (2012-2022)
1.4.4 Europe PDE Inhibitors Status and Prospect (2012-2022)
1.4.5 Japan PDE Inhibitors Status and Prospect (2012-2022)
1.4.6 Southeast Asia PDE Inhibitors Status and Prospect (2012-2022)
1.4.7 India PDE Inhibitors Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of PDE Inhibitors (2012-2022)
1.5.1 Global PDE Inhibitors Sales and Growth Rate (2012-2022)
1.5.2 Global PDE Inhibitors Revenue and Growth Rate (2012-2022)

2 Global PDE Inhibitors Competition by Players/Suppliers, Type and Application
2.1 Global PDE Inhibitors Market Competition by Players/Suppliers
2.1.1 Global PDE Inhibitors Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global PDE Inhibitors Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global PDE Inhibitors (Volume and Value) by Type
2.2.1 Global PDE Inhibitors Sales and Market Share by Type (2012-2017)
2.2.2 Global PDE Inhibitors Revenue and Market Share by Type (2012-2017)
2.3 Global PDE Inhibitors (Volume and Value) by Region
2.3.1 Global PDE Inhibitors Sales and Market Share by Region (2012-2017)
2.3.2 Global PDE Inhibitors Revenue and Market Share by Region (2012-2017)
2.4 Global PDE Inhibitors (Volume) by Application

3 United States PDE Inhibitors (Volume, Value and Sales Price)
3.1 United States PDE Inhibitors Sales and Value (2012-2017)
3.1.1 United States PDE Inhibitors Sales and Growth Rate (2012-2017)
3.1.2 United States PDE Inhibitors Revenue and Growth Rate (2012-2017)
3.1.3 United States PDE Inhibitors Sales Price Trend (2012-2017)
3.2 United States PDE Inhibitors Sales Volume and Market Share by Players
3.3 United States PDE Inhibitors Sales Volume and Market Share by Type
3.4 United States PDE Inhibitors Sales Volume and Market Share by Application

4 China PDE Inhibitors (Volume, Value and Sales Price)
4.1 China PDE Inhibitors Sales and Value (2012-2017)
4.1.1 China PDE Inhibitors Sales and Growth Rate (2012-2017)
4.1.2 China PDE Inhibitors Revenue and Growth Rate (2012-2017)
4.1.3 China PDE Inhibitors Sales Price Trend (2012-2017)
4.2 China PDE Inhibitors Sales Volume and Market Share by Players
4.3 China PDE Inhibitors Sales Volume and Market Share by Type
4.4 China PDE Inhibitors Sales Volume and Market Share by Application

5 Europe PDE Inhibitors (Volume, Value and Sales Price)
5.1 Europe PDE Inhibitors Sales and Value (2012-2017)
5.1.1 Europe PDE Inhibitors Sales and Growth Rate (2012-2017)
5.1.2 Europe PDE Inhibitors Revenue and Growth Rate (2012-2017)
5.1.3 Europe PDE Inhibitors Sales Price Trend (2012-2017)
5.2 Europe PDE Inhibitors Sales Volume and Market Share by Players
5.3 Europe PDE Inhibitors Sales Volume and Market Share by Type
5.4 Europe PDE Inhibitors Sales Volume and Market Share by Application

6 Japan PDE Inhibitors (Volume, Value and Sales Price)
6.1 Japan PDE Inhibitors Sales and Value (2012-2017)
6.1.1 Japan PDE Inhibitors Sales and Growth Rate (2012-2017)
6.1.2 Japan PDE Inhibitors Revenue and Growth Rate (2012-2017)
6.1.3 Japan PDE Inhibitors Sales Price Trend (2012-2017)
6.2 Japan PDE Inhibitors Sales Volume and Market Share by Players
6.3 Japan PDE Inhibitors Sales Volume and Market Share by Type
6.4 Japan PDE Inhibitors Sales Volume and Market Share by Application

7 Southeast Asia PDE Inhibitors (Volume, Value and Sales Price)
7.1 Southeast Asia PDE Inhibitors Sales and Value (2012-2017)
7.1.1 Southeast Asia PDE Inhibitors Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia PDE Inhibitors Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia PDE Inhibitors Sales Price Trend (2012-2017)
7.2 Southeast Asia PDE Inhibitors Sales Volume and Market Share by Players
7.3 Southeast Asia PDE Inhibitors Sales Volume and Market Share by Type
7.4 Southeast Asia PDE Inhibitors Sales Volume and Market Share by Application

8 India PDE Inhibitors (Volume, Value and Sales Price)
8.1 India PDE Inhibitors Sales and Value (2012-2017)
8.1.1 India PDE Inhibitors Sales and Growth Rate (2012-2017)
8.1.2 India PDE Inhibitors Revenue and Growth Rate (2012-2017)
8.1.3 India PDE Inhibitors Sales Price Trend (2012-2017)
8.2 India PDE Inhibitors Sales Volume and Market Share by Players
8.3 India PDE Inhibitors Sales Volume and Market Share by Type
8.4 India PDE Inhibitors Sales Volume and Market Share by Application

9 Global PDE Inhibitors Players/Suppliers Profiles and Sales Data
9.1 Hanmi Science Holding
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 PDE Inhibitors Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Hanmi Science Holding PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Boehringer Ingelheim
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 PDE Inhibitors Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Boehringer Ingelheim PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Takeda Pharmaceuticals
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 PDE Inhibitors Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Takeda Pharmaceuticals PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Pfizer
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 PDE Inhibitors Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Pfizer PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Omeros
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 PDE Inhibitors Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Omeros PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Anacor Pharmaceuticals
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 PDE Inhibitors Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Anacor Pharmaceuticals PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Otsuka
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 PDE Inhibitors Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Otsuka PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Chiesi Farmaceutici
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 PDE Inhibitors Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Chiesi Farmaceutici PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Verona Pharma
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 PDE Inhibitors Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Verona Pharma PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 NuSirt Biopharma
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 PDE Inhibitors Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 NuSirt Biopharma PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview

10 PDE Inhibitors Maufacturing Cost Analysis
10.1 PDE Inhibitors Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of PDE Inhibitors
10.3 Manufacturing Process Analysis of PDE Inhibitors

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 PDE Inhibitors Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of PDE Inhibitors Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global PDE Inhibitors Market Forecast (2017-2022)
14.1 Global PDE Inhibitors Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global PDE Inhibitors Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global PDE Inhibitors Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global PDE Inhibitors Price and Trend Forecast (2017-2022)
14.2 Global PDE Inhibitors Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global PDE Inhibitors Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global PDE Inhibitors Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States PDE Inhibitors Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China PDE Inhibitors Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe PDE Inhibitors Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan PDE Inhibitors Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia PDE Inhibitors Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India PDE Inhibitors Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global PDE Inhibitors Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global PDE Inhibitors Sales Forecast by Type (2017-2022)
14.3.2 Global PDE Inhibitors Revenue Forecast by Type (2017-2022)
14.3.3 Global PDE Inhibitors Price Forecast by Type (2017-2022)
14.4 Global PDE Inhibitors Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer


Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 37985

Category: 16

Published date: 2017-12-03 20:12:16

Number of Pages: 105

Publisher Name:

Over all Rating: 0 % (Average of Ratings provided by clients)